F
Feng Zhang
Researcher at Fudan University
Publications - 2715
Citations - 225233
Feng Zhang is an academic researcher from Fudan University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 172, co-authored 1278 publications receiving 181865 citations. Previous affiliations of Feng Zhang include Cincinnati Children's Hospital Medical Center & Nanjing Medical University.
Papers
More filters
Journal ArticleDOI
Enriched environment preconditioning induced brain ischemic tolerance without reducing infarct volume and edema: the possible role of enrichment-related physical activity increase.
Hongyu Xie,Yi Wu,Jie Jia,Gang Liu,Feng Zhang,Qi Zhang,Kewei Yu,Yongshan Hu,Yulong Bai,Ruiping Hu +9 more
TL;DR: This study showed that PIEE improved the recovery of motor function, spatial learning and memory without reduction in brain edema or infarct volume and found thatPIEE robustly increased the level of physical activity of rats that positively correlated with the extent of neurobehavioral recovery.
Journal ArticleDOI
Genome-wide association study identifies ITPR2 as a susceptibility gene for Kashin-Beck disease in Han Chinese.
Feng Zhang,Yan Wen,Xiong Guo,Yin-gang Zhang,Xi Wang,Tie-Lin Yang,Hui Shen,Xiang-Ding Chen,Qing Tian,Hong-Wen Deng +9 more
TL;DR: The aim of this study was to identify susceptibility genes for KBD by conducting a 2‐stage genome‐wide association study (GWAS).
Patent
Spatial and cellular mapping of biomolecules in situ by high-throughput sequencing
TL;DR: In this paper, the authors used proximal unique molecular identifiers reaction (VIPUR) microscopy methods to record the cellular co-localization and/or spatial distributions of arbitrary nucleic acid sequences, or other biomolecules tagged with nucleic sequences.
Journal ArticleDOI
Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective study.
TL;DR: The results indicate the challenge of PPI use was accompanied by unapproved indications, frequent inappropriate co-prescription with GCs and excessive dosages.
Patent
Crispr mediated in vivo modeling and genetic screening of tumor growth and metastasis
TL;DR: In this paper, in-vivo methods for modeling tumor formation and/or tumor evolution comprising the use of eukaryotic cells in which one or more genetic target locus has been altered by the CRISPR/Cas system, and which cells are transplanted in non-human Eukaryote as a model system for tumor creation and tumor evolution are disclosed.